The Evidence to Date: A Redox-Inactive Analogue of Tocotrienol as a New Anti-Mesothelioma Agent

Journal of Rare Diseases Research & Treatment
doi 10.29245/2572-9411/2017/1.1072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sciaccess Publishers LLC

Related search

Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

Evidence Surveillance to Keep Up to Date With New Research

2018English

Understanding the Harms of HES: A Review of the Evidence to Date

Turkish Journal of Anaesthesiology and Reanimation
AnesthesiologyPain MedicineEmergency Medicine
2019English

Management of Psoriasis in Pregnancy – A Review of the Evidence to Date

Drugs in Context
Molecular MedicinePharmacology
2020English

P2.06-20 Bacteria as Novel Anti-Mesothelioma Agents.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Tuning the Redox Properties of a Nonheme Iron(III)-Peroxo Complex Binding Redox-Inactive Zinc Ions by Water Molecules

Chemistry - A European Journal
Organic ChemistryCatalysisChemistry
2015English

Synthesis of a Novel Dicyano Abietane Analogue: A Potential Antiinflammatory Agent

Journal of Organic Chemistry
Organic Chemistry
2006English

Largazole as a Novel and Selective Anti-Breast Cancer Agent

2011English

The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy